New York: Just one dose of the human papillomavirus (HPV) vaccine may prevent infection from a potentially cancer-causing virus, suggests new research.
Results of the study, which included only women participants published in the journal JAMA Network Open, suggest that a single dose of HPV vaccine may be as effective as the currently recommended two- or three-dose series.
However, it is too early for people to rely on a single dose of the vaccine for protection, according to senior author Ashish Deshmukh, Assistant Professor at The University of Texas Health Science Center at Houston (UTHealth).
“HPV vaccine coverage is less than 10 percent globally because of poor vaccine uptake rates in many resource-limited countries. Ensuring boys and girls receive their first dose is a big challenge in several countries and a majority of adolescents are not able to complete the recommended series due to a lack of intensive infrastructure needed to administer two or three doses,” Deshmukh said.
“If ongoing clinical trials provide evidence regarding sustained benefits of a one-dose regimen, then implications of single-dose strategy could be substantial for reducing the burden of these cancers globally,” he added. According to the US Centers for Disease Control (CDC), 34,800 new cancer diagnoses are linked to HPV annually. (IANS)
Also Read: HOUSEFLIES – THE PORTERS OF INFECTION
Also Watch: Anti-CAA protests: AASU and Artistes Society of Assam jointly conducts protest meeting in Sualkuchi